* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Biohazardous Materials/rDNA Summary Form
DNA polymerase wikipedia , lookup
Primary transcript wikipedia , lookup
SNP genotyping wikipedia , lookup
DNA profiling wikipedia , lookup
Bisulfite sequencing wikipedia , lookup
DNA damage theory of aging wikipedia , lookup
Microevolution wikipedia , lookup
Gel electrophoresis of nucleic acids wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Non-coding DNA wikipedia , lookup
Epigenomics wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Genomic library wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Genealogical DNA test wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Genetic engineering wikipedia , lookup
Nucleic acid double helix wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
United Kingdom National DNA Database wikipedia , lookup
Helitron (biology) wikipedia , lookup
DNA supercoil wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
DNA vaccination wikipedia , lookup
SUMMARY FOR GRANT SUBMISSIONS RECOMBINANT DNA/BIOHAZARDOUS MATERIALS NEOMED INSTITUTIONAL BIOSAFETY COMMITTEE PI Name: Granting Agency Name: Title of Proposal: ______________________________________________________________________________________ ___ RECOMBINANT DNA Please provide the following information regarding any recombinant DNA you are using in the above mentioned proposal: What is the name of the recombinant DNA sequence? What is the name of the virus or plasmid used for constructing the recombinant? Will more than 10L of cell culture per experiment be produced? Yes No What is the source of the rDNA material you are using? ( i.e. name of vendor, name of colleague) What is the room number where rDNA material will be used and stored: ______________________________________________________________________________________ BIOHAZARDOUS MATERIALS Please provide the following information regarding any biohazardous materials you are using in the above mentioned proposal: What is the name and description of the biohazardous material(s): (example: E. Coli- bacteria, nematoda – parasite, osteosarcoma- human tissue samples) What is the source of the biohazardous material? ( i.e. name of the vendor, name of the colleague, etc.): What is the room number where biohazardous material will be used and stored: ________________________________________________________________________________________________________ Statement of Understanding: I understand if the above mentioned application is funded, I will be required to complete a full IBC application for formal review/exemption of the rDNA experiments proposed in this application as well as for registration of other biohazardous materials I may be using. PI Signature: Date: _________________________________________________ ____________________________ *Please attach this form to the back of your completed grant routing form prior to bringing to the ORSP. This form will then be placed on the grants workflow and reviewed electronically by the Chair of the NEOUCOM IBC. You will receive an email when this form has been approved and authorization from the IBC has been given to submit this proposal. Proposals may not be submitted to any funding agency prior to obtaining all required compliance committee authorizations (IRB, IBC, RSC, IACUC).